1. A pharmaceutical composition comprising at least one compound of formula (I) where the radicals denote: R is hydrogen, CC-alkyl, CC-cycloalkyl, CC-aryl, carboxy or C-tiokarb in particular hydrogen or CC-alkyl, R is hydrogen, CC-alkyl, CC-cycloalkyl, CC-aryl, carboxy or C-tiokarb in particular hydrogen or CC-alkyl, R is hydrogen or a CC-alkyl, in particular methyl, R is OH or OCC-alkyl, in particular OH, R is hydrogen or a CC-alkyl, in particular hydrogen, and / or a pharmaceutically acceptable salt, and / or a stereoisomeric form thereof or a derivative thereof, and at least one pharmaceutically acceptable cyclodextrin derivative (C) and optionally further components (F) .2. . The pharmaceutical composition according to claim 1, wherein the composition comprises at least one compound of formula (I), wherein radicals designated: R is hydrogen, CC-alkyl, CC-cycloalkyl or CC-aryl, R is hydrogen, CC-alkyl, CC-cycloalkyl or CC-aryl, R is hydrogen or a CC-alkyl, R is OH or OCC-alkyl, R is hydrogen or a CC-alkyl, in particular hydrogen, and / or a pharmaceutically acceptable salt thereof, and comprises at least one additional component (F) .3. A pharmaceutical composition according to Claim. 1, wherein the composition comprises a compound of formula (I), gdeRpredstavlyaet hydrogen or CC-alkyl, R is hydrogen or a CC-alkyl, R is hydrogen or methyl, R is OH, R is hydrogen or a CC-alkyl, in particular hydrogen, and / or a pharmaceutically acceptable salt thereof, and contains water as solvent and optionally further com1. Фармацевтическая композиция, содержащая, по меньшей мере, одно соединение формулы (I)где радикалы обозначают:R1 представляет собой водород, C1-C8-алкил, C3-C8-циклоалкил, C6-C14-арил, карбокси или C-тиокарб в частности водород или C1-C3-алкил,R2 представляет собой водород, C1-C8-алкил, C3-C8-циклоалкил, C6-C14-арил, карбокси или C-тиокарб в частности водород или C1-C3-алкил,R3 представляет собой водород или C1-C8-алкил, в частности метил,R4 представляет соб
